World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. ATAI Life Sciences N.V.

    World Rank (Jan-05-2024)
    16,036
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    15,102
    Market Cap (Jul-30-2023)
    0.342 Billion USD
    World Rank (Dec-25-2022)
    13,197
    Market Cap (Dec-25-2022)
    0.443 Billion USD
    World Rank (Jan-07-2022)
    9,233
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Headquarters Country
    Germany
    Yahoo @ Nasdaq
    Company Profile
    Atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Headquarters is in Germany.
    Company Website
    ATAI LIFE SCIENCES N.V.

  2. Verrica Pharmaceuticals

    World Rank (Jan-05-2024)
    16,042
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    17,040
    Market Cap (Jul-30-2023)
    0.242 Billion USD
    World Rank (Dec-25-2022)
    21,504
    Market Cap (Dec-25-2022)
    0.103 Billion USD
    World Rank (Jan-07-2022)
    17,721
    Market Cap (Jan-07-2022)
    0.25 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -43 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    VERRICA PHARMACEUTICALS

  3. Lyra Therapeutics Inc.

    World Rank (Jan-05-2024)
    16,072
    Market Cap (Jan-05-2024)
    0.285 Billion USD
    World Rank (Jul-30-2023)
    19,161
    Market Cap (Jul-30-2023)
    0.163 Billion USD
    World Rank (Dec-25-2022)
    21,684
    Market Cap (Dec-25-2022)
    0.099 Billion USD
    World Rank (Jan-07-2022)
    25,524
    Market Cap (Jan-07-2022)
    0.06 Billion USD
    Headquarters Country
    USA
    Company Website
    LYRA THERAPEUTICS, INC.

  4. Pharmicell

    World Rank (Jan-05-2024)
    16,073
    Market Cap (Jan-05-2024)
    0.285 Billion USD
    World Rank (Jul-30-2023)
    15,674
    Market Cap (Jul-30-2023)
    0.308 Billion USD
    World Rank (Dec-25-2022)
    11,903
    Market Cap (Dec-25-2022)
    0.541 Billion USD
    World Rank (Jan-07-2022)
    11,903
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    South Korea
    Yahoo @ SouthKorea

  5. GH Research PLC

    World Rank (Jan-05-2024)
    16,085
    Market Cap (Jan-05-2024)
    0.284 Billion USD
    World Rank (Jul-30-2023)
    10,432
    Market Cap (Jul-30-2023)
    0.732 Billion USD
    World Rank (Dec-25-2022)
    12,316
    Market Cap (Dec-25-2022)
    0.507 Billion USD
    World Rank (Jan-07-2022)
    9,593
    Market Cap (Jan-07-2022)
    0.97 Billion USD
    Headquarters Country
    Ireland
    Company Profile
    GH Research PLC is a clinical stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The headquarters is in Ireland.
    Company Website
    GH RESEARCH PLC

  6. ESSA Pharma Inc.

    World Rank (Jan-05-2024)
    16,094
    Market Cap (Jan-05-2024)
    0.283 Billion USD
    World Rank (Jul-30-2023)
    20,380
    Market Cap (Jul-30-2023)
    0.128 Billion USD
    World Rank (Dec-25-2022)
    23,440
    Market Cap (Dec-25-2022)
    0.070 Billion USD
    World Rank (Jan-07-2022)
    12,927
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Headquarters Country
    Canada
    Yahoo @ TSXVCanada
    Company Website
    ESSA PHARMA

  7. Immunotech Biopharm Ltd

    World Rank (Jan-05-2024)
    16,128
    Market Cap (Jan-05-2024)
    0.282 Billion USD
    World Rank (Jul-30-2023)
    16,313
    Market Cap (Jul-30-2023)
    0.276 Billion USD
    World Rank (Dec-25-2022)
    15,458
    Market Cap (Dec-25-2022)
    0.313 Billion USD
    World Rank (Jan-07-2022)
    8,871
    Market Cap (Jan-07-2022)
    1.11 Billion USD
    Headquarters Country
    China
    Company Website
    IMMUNOTECH BIOPHARM LTD

  8. Bluebird Bio

    World Rank (Jan-05-2024)
    16,197
    Market Cap (Jan-05-2024)
    0.279 Billion USD
    World Rank (Jul-30-2023)
    13,845
    Market Cap (Jul-30-2023)
    0.420 Billion USD
    World Rank (Dec-25-2022)
    11,315
    Market Cap (Dec-25-2022)
    0.595 Billion USD
    World Rank (Jan-07-2022)
    11,640
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Net Income in USD
    -819 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bluebird Bio is a Gene Therapy and Pharmaceutical company. It is working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases. The company is Powered by multiple labs, in house lentiviral vector manufacturing capabilities and future drug product production and it push to find answers for the people who need them by exploring the cutting edge spectrum of gene therapy. The headquarters is in USA.
    Company Website
    BLUEBIRD BIO INC

  9. Mersana Therapeutics

    World Rank (Jan-05-2024)
    16,205
    Market Cap (Jan-05-2024)
    0.279 Billion USD
    World Rank (Jul-30-2023)
    19,774
    Market Cap (Jul-30-2023)
    0.144 Billion USD
    World Rank (Dec-25-2022)
    11,492
    Market Cap (Dec-25-2022)
    0.578 Billion USD
    World Rank (Jan-07-2022)
    14,071
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Mersana Therapeutics is a Biopharmaceutical company specializing in the discovery and development of antibody drug conjugate (ADC) therapies to treat patients fighting cancer. The company total assets is 107.5 million USD as on 2019, total liabilities is 29.2 million USD as on 2019, annual revenue is 42.1 million USD as on 2019 and total equity is 78.3  million USD as on 2019.The headquarters is in USA.
    Company Website
    MERSANA THERAPEUTICS

  10. Humacyte Inc.

    World Rank (Jan-05-2024)
    16,215
    Market Cap (Jan-05-2024)
    0.278 Billion USD
    World Rank (Jul-30-2023)
    15,669
    Market Cap (Jul-30-2023)
    0.309 Billion USD
    World Rank (Dec-25-2022)
    17,129
    Market Cap (Dec-25-2022)
    0.237 Billion USD
    World Rank (Jan-07-2022)
    11,893
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -26 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile

    Humacyte is a Clinical Stage Biotechnology Platform company developing universally implantable bioengineered human tissue at a commercial scale with the goal of improving the lives of patients and transforming the practice of medicine. The company total assets are 101 million USD as on 2020. The headquarters is in USA.

    Company Website
    HUMACYTE, INC.

Share